Search Results

Welcome Back, Discovery Drivers   Terry’s Corner is live, on-demand pharmacology built for drug discovery Dr.GPCR Updates Terry’s Corner is Live - Pharmacology at your fingertips Terry’s Corner is now open! Terry Kenakin with short videos, clear summaries, and curated references. Want the full breakdown and your discount code for Terry's Corner? Better pharmacology leads to better decisions—unlock it now with Terry’s Corner.

Hello GPCR Innovators ,   We’re preparing to launch Terry’s Corner, a new knowledge hub shaped by Dr. Terry Kenakin’s decades of GPCR insight. ST171, a biased 5‑HT1A agonist, delivers selective pain relief in preclinical models Dr.GPCR Updates Terry Terry’s Corner gives you timeless and timely tools to improve selectivity, model efficacy, and design

One of its first pillars, Terry’s Pharmacology Corner , led by Dr. Terry Kenakin , continues to grow. Through Terry’s Pharmacology Corner , he shares decades of expertise in an accessible, on-demand format Terry Kenakin , a pioneer who helped shape modern pharmacology and deepen our understanding of GPCR function Related Links 🔗 Explore Terry’s Pharmacology Corner → TerryKenakin.com 📧 Connect with us →   Hello@

Hello GPCR Minds,   This week, you'll learn all about Terry’s Pharmacology Corner, your new learning Terry Kenakin   Terry’s Corner is your space focused on GPCR pharmacology designed just for you.   Terry Kenakin brings translational clarity to complex receptor concepts.  

Terry’s Corner is coming soon. Dr. GPCR Updates Terry’s Corner Is Coming – Get Early Access and Updates    Terry’s Corner is launching Terry Kenakin. Explore Terry's Corner From Chemistry Lab to GPCR Partner – New Podcast with Celtarys Dr. Terry’s Corner is coming soon. Stay curious, The Dr. GPCR Team

Today, we're thrilled to announce that Terry's Corner is officially live !   What's inside Terry's Corner?   GPCR Premium Members a significantly reduced access  to Terry's Corner for a limited time.   Explore Terry's Corner Better decisions start with better pharmacology. GPCR Team & Terry’s Desk

In the foundational lesson of Terry’s Corner , Dr. Terry Kenakin invites us to challenge outdated assumptions and step into a new era of drug discovery. Now, Terry is opening the vault. This isn’t theory. Join Terry’s Corner and stay updated on the latest in GPCR research—delivered in a format that’s as approachable Unlock "Why Terry's Corner" now

That’s exactly what Terry’s Corner delivers this week: high-impact insight into GPCR allostery, crafted Terry's Corner : Stop Chasing Affinity and Start Reading the System In this week’s cornerstone Terry’ Terry Kenakin reframes GPCRs as dynamic, allosteric sensors—far from static binding sites. Terry Kenakin on “The Kinetics of Allostery: The Added Benefits of Allosteric Function.”

I’m honored to be chairing a session  in this track — with none other than Terry Kenakin  on the speaker Takeda   🎥 Interview with Kris Borzilleri & Alison Heick Varghese from Pfizer 🎥 Interview with Terry Kenakin from UNC and Terry's Corner We'll continue to update this section as new videos are released   📚 Terry’s Corner — The Only On-Demand Pharmacology Hub with Dr. For those who can’t get enough of Terry’s insights at Discovery on Target, Terry’s Corner  keeps the

Kenakin from Terry's Corner shows how to tame irreversible drugs so their kinetic power works for you Terry's Corner – Control Target Engagement—Don’t Chase It with Irreversible Drugs When binding outlives Kenakin Trusted insights from biotech, pharma, and academia 🎬 Plus New: Lesson Trailers   Curious about Terry

That’s exactly what Terry’s Corner delivers this week: a deep dive into molecular creativity, rational Terry’s Corner: Why Chemistry Still Rules For decades, discovery focused on targets. Terry Kenakin reveals how drug chemistry defines function, not just fit. Learn what’s next. 🟢 Premium Members get 50%+ discount when they join Terry’s Corner. 👉 Access this

Ho, ho, ho, GPCR elves! As the year wraps up, we're thrilled to present the final edition of the GPCR Weekly Newsletter for 2024! As researchers, we all understand the importance of data in driving meaningful discoveries  and advancing our experiments.   At Dr. GPCR, we believe the same principle applies to building a better experience  for our online community.   We’d love to hear your thoughts on our website and its features  so that we can continue to support your work and foster collaborations in the GPCR field.   Your feedback  will guide us in tailoring resources , tools , and content to meet your needs better and help fuel your research. Thank you for sharing your perspective and helping us shape the future of the Dr. GPCR ecosystem! Best, Yamina & the Dr. GPCR Team This Week’s Highlights: Congratulations to Andrew Tobin for an incredible week filled with prestigious events, including receiving the British Pharmacological Society Vane Medal and switching on the Christmas lights at the University of Glasgow Advanced Research Centre! Activation of the proton-sensing GPCR, GPR65 on fibroblast-like synoviocytes contributes to inflammatory joint pain Luke A Pattison , Rebecca H Rickman , Graham Ladds , Ewan St John Smith , et al. Attention, everyone! This is your last chance before the curtain closes: Classified GPCR News will be accessible only to VIP members next year! Indeed, all the details below will be limited to Premium Members . Don't miss out—upgrade now to keep up with your GPCR updates! Classified GPCR News  Let’s dive into the   Classified GPCR News from December 9th to 15th, 2024 Industry News When science meets serendipity: How accidental discoveries could revolutionise women’s health Seven unanswered questions about blockbuster weight-loss drugs Transforming Drug Discovery: Insights from Viva Biotech's GPCR and TPD Structural Biology Platforms GPCR Events, Meetings, and Webinars December 10 - 12, 2024 | Pharmacology 2024 January 13 - 16, 2025 | PepTalk 2025 January 25 - 29, 2025 | SLAS 2025 February 15 - 16, 2025 | Structural and Functional Approaches in GPCR Drug Discovery February 15 - 19, 2025 | BPS 2025 February 16 - 21, 2025 | Harnessing the Power of Advanced Multimodal Approaches to GPCR Drug Discovery March 12 - 14, 2025 | NextGen Biomed 2025 March 25 - 28, 2025 | 10th German Pharm-Tox Summit April 1 - 5, 2025 | XXIII GEM Meeting in 2025 April 3 - 6, 2025 | ASPET 2025 April 14 - 17, 2025 | 20th Drug Discovery Chemistry April 24 - 27, 2025 | American Physiology Summit 2025 April 25 - 30, 2025 | AACR Annual Meeting 2025 May 12 - 15, 2025 | PEGS 2025 May 20 - 22, 2025 | SLAS Europe 2025 June 16 - 19, 2025 | BIO International Convention 2025 July 12 - 17, 2026 | 20th World Congress of Basic and Clinical Pharmacology GPCR Jobs GPCR Molecular Pharmacologist Scientist - Biology Scientist I Cell Biology - Tectonic Therapeutic Senior Principal Scientist, Medicinal Chemistry PhD fellowship in GPCR mechanosensing Senior Scientist, GPCR Pharmacology Research Associate - Professor Graeme Milligan Postdoc in Molecular Pharmacology - The Hauser Group Postdoctoral Scholar – iPSC in cardiac and endothelial cell function Protein Biochemist/Structural Biologist GPCR Activation and Signaling Activation of the proton-sensing GPCR, GPR65 on fibroblast-like synoviocytes contributes to inflammatory joint pain Regulation of the chemokine receptors CXCR4 and ACKR3 by receptor activity-modifying proteins Single-cell transcriptomics of vomeronasal neuroepithelium reveals a differential endoplasmic reticulum environment amongst neuronal subtypes Methods & Updates in GPCR Research High-throughput optimisation of protein secretion in yeast via an engineered biosensor Optimized vector for functional expression of the human bitter taste receptor TAS2R14 in HEK293 cells Reviews, GPCRs, and more The role of the endocannabinoid system in the pathogenesis and treatment of epilepsy Become a Premium Member! Get your 5-day free trial TODAY!

Nicole (Nicki) Perry-Hauser is now available What a fun chat! 📹Would you like to see the video?

Terry Kenakin’s newest foundational lesson in Terry's Corner  cuts straight to it:   Why models are vital Probability Models   This is practical drug development expertise from Terry’s 40+ years of experience Beyond the lessons, Terry's Corner  is your exclusive gateway.

This week in Terry’s Corner, Dr. But Terry explains why those assumptions don’t always hold. Unlock “Competitive Antagonism” Now Only in Terry’s Corner Why Terry’s Corner For discovery-phase teams Terry’s Corner  is built to help you avoid those traps. But Terry cautions: “These patterns are consistent with, but not proof of, mechanism.

Welcome to Terry’s Corner , where foundational pharmacology is demystified by someone who’s spent over In his newest lesson, “The Uniqueness of Pharmacology in Drug Discovery,” Terry Kenakin explains why Whether you're heading into your first assay or trying to make sense of inconsistent data, Terry gives Don’t just look at the data—learn how to read the story it’s telling. 👉 Start your journey with Terry

In this eye-opening module, Terry Kenakin explores a concept that could change how you interpret pharmacological Through powerful analogies (think batteries and balance scales), Terry reveals why different tissues—and emerging drug hunter, this lesson is your bridge from data confusion to predictive clarity. 👉 Dive into Terry

In Terry Kenakin’s latest lesson, you’ll uncover why efficacy is the unsung hero of drug discovery and Terry walks you through real-world experiments, decades of receptor pharmacology wisdom, and the cutting-edge 🔓 Find the lesson in Terry’s Pharmacology Vault: “Efficacy and System Sensitivity Unlock "Agonism &

In this foundational lesson, Terry Kenakin dives deep into a widely used, often misunderstood tool in Through real-world examples (like 5-HT2A and CCR5 agonists), Terry shows how slow-onset agonists can missteps, and use calcium assays with strategic clarity. 📍 Foundational Level | Calcium Assays 📚 Part of Terry

Terry Kenakin , a veteran pharmacologist with over 40 years of industry experience. In this foundational-level  lesson, Terry unpacks the real-life process behind discovering new drugs, trees The critical importance of translation —turning lab data into meaningful therapeutic outcomes Terry

That’s exactly what Terry’s Corner  delivers this week: real-world kinetic frameworks to help you move Terry’s Corner: Why Binding Kinetics Matter More Than Affinity In drug discovery today, time wasted is Terry Kenakin’s latest lecture in Terry’s Corner  delivers exactly what your discovery teams need now Premium Members get 50%+ discount when they join Terry’s Corner. 🔒 Available only in Terry’s Corner Terry Kenakin’s featured talk on “The Kinetics of Allostery” offers a rare live glimpse into advanced

Terry has seen this story play out for 40 years — and he’s helping rewrite the ending. That’s exactly what Terry’s Corner  was built to do: bring four decades of frontline discovery insight Terry’s Corner is designed to shorten that distance between initial promise and actionable clarity. How better CRO communication prevents costly errors. 👉  Join Terry’s Corner & Secure Your Spot for the October 30 AMA Why Terry’s Corner Terry’s Corner  is a living, growing knowledge hub led by Terry Kenakin—a

In this exclusive Expert Drug Hunter lesson, Terry Kenakin dismantles 100 years of receptor theory and Step into Terry’s Vault and explore “Molecular Dynamics”—where expert drug hunters forge the future.

In the newest foundational lesson from Terry Kenakin’s Pharmacology Vault , we unlock the visual language In classic Terry style, the lecture walks you through: What dose-response curves are and why they’re

That’s precisely why Terry’s Corner delivers this week: practical, statistical tools that let you move Terry Kenakin walks you through which statistical tests actually answer the question you think you’re Premium Members get a 50%+ discount when they join Terry’s Corner. 🚨 First-ever Live AMA with Dr. Kenakin  happens this month—exclusively inside Terry’s Corner. Bring the curve you’re debating. Unlock Terry’s Corner ➤ Dr. GPCR Podcast – Ajay Yekkirala on GPCR Innovation In this episode, Dr.

That’s precisely what Terry’s Corner delivers every week: practical tools from Dr. Terry Kenakin to elevate your science and sharpen your decisions. Premium Members get a 50%+ discount when they join Terry’s Corner. 🚨 First-ever Live AMA with Dr. Kenakin  is happening September 18th, 12- 1 pm EST —exclusively inside Terry’s Corner. Join Terry's Corner Today ➤ Celtarys Research – Confocal Imaging That Preserves GPCR Function Confocal

Terry’s Pharmacology Corner  delivers trusted, razor-sharp insight to help drug discovery professionals Unlock “GPCRs as Allosteric Machines” Now Only in Terry’s Corner Why Terry’s Corner Terry’s Pharmacology Terry Kenakin Monthly Ask-Me-Anything sessions A growing, curated on-demand library Opportunities to

Instead of treating binding as a binary event, Terry shows you how to interrogate whether your compound Allosteric Interactions Only in Terry’s Corner 🎬 Plus New: Lesson Trailers   Curious about Terry’s Corner   👉 Explore Trailers & Join Today Why Terry’s Corner The reality is dynamic—ligands compete, cooperate That’s where Terry’s Corner changes the game. on-demand library  of expert pharmacology lessons you can revisit anytime Monthly AMAs  where you can ask Terry

That’s precisely what Terry’s Corner delivers each week: practical frameworks from Dr. Terry Kenakin to elevate your science and sharpen your calls. Premium Members get a 50%+ discount when they join Terry’s Corner. 🚨 Live AMA with Dr. Kenakin is today, September 18th, 12-1 pm EST in Terry’s Corner. You an Edge Premium delivers curated, noise-free intelligence every week: expert frameworks  (like Terry

Terry Kenakin takes you on a captivating tour through the history of pharmacology : a journey that spans 👉 Join Terry’s Corner, your essential launchpad into the world of therapeutic science Unlock "The History